Editorial Policy

At ZENTRA Peptides, we are committed to providing accurate, scientifically grounded, and transparent information regarding our products. Our editorial policy ensures that all content published on our platform meets the highest standards of integrity and serves the specific needs of the scientific community.

Research Scope

ZENTRA Peptides supplies research compounds intended strictly for laboratory and in-vitro use. Our content is written exclusively for qualified researchers, academic institutions, and scientific professionals. We do not provide, nor do we permit the publication of, any content that suggests or encourages the use of our products for human or veterinary consumption.

Review Process

All technical content, including product descriptions, storage guidelines, and laboratory handling protocols, is thoroughly reviewed by the ZENTRA Research Team before publication. This internal review process ensures that the information aligns with current scientific understanding and our strict operational guidelines.

Fact-Checking and Accuracy

We take accuracy seriously. Any claims regarding the physical properties, molecular weight, purity, or stability of our compounds are verified against independent third-party laboratory Certificates of Analysis (CoAs) and published manufacturer documentation. When referencing external studies or mechanisms of action, we rely on peer-reviewed scientific literature to ensure factual correctness.

Research-Use-Only Stance

In strict compliance with regulatory requirements, our editorial content will never contain medical advice, therapeutic claims, or dosage recommendations. We explicitly prohibit any language that could be construed as endorsing the clinical application of research peptides. Our focus remains solely on the chemical properties, proper handling, and storage of these compounds for analytical research.

Corrections Policy

We are dedicated to maintaining the accuracy of our published materials. If an error or inaccuracy is identified in our content, we are committed to correcting it promptly. Updates and corrections will be applied directly to the relevant pages to ensure researchers always have access to the most current and precise information.

Conflicts of Interest

ZENTRA Peptides operates with full editorial independence. We do not accept sponsored content or paid endorsements that could compromise the objectivity of our scientific information. Our primary objective is to support the research community with reliable, high-purity compounds and accurate data.

Company Information

ZENTRA Peptides is a trading name of Zentra Compounds Limited.
Company Number: 17212134
Registered Address: Legion House, 75 Lower Road, Kenley, CR8 5NH, United Kingdom.